James F. Leary Elected SPIE Fellow
March 22, 2012
BELLINGHAM, Washington, USA – March 20, 2012 – Each year, SPIE promotes members as new Fellows of the Society. SPIE will honor 75 new Fellows of the Society this year. Fellows are members of distinction who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and imaging. They are honored for their technical achievement, for their service to the general optics community, and to SPIE in particular. More than 900 SPIE members have become Fellows since the Society’s inception in 1955.
“The annual recognition of Fellows provides an opportunity for us to acknowledge Members for their outstanding technical contributions and service to SPIE,” says Eustace L. Dereniak, SPIE President.
James F. Leary, Purdue University, United States, for achievements in high-speed flow cytometry and nanomedicine.
Leary has made pioneering developments in the areas of tissue engineering, biophotonics, and nanomedicine over more than 30 years. Specifically, he developed high-speed flow cytometry for the detection and isolation of rare cells, which is key for identifying and treating infectious diseases, cancer, and in gene therapy.
He has made many breakthroughs in the field of biophotonics and microfluidics including the development of bioMEMS microfluidic devices and point-of-care medical devices such as a hand-held blood analyzer for use in space and in pediatric scale blood analysis of newborns, as well as portable multimodal lab-on-a-chip technology for testing for pathogens in food. Additionally, Leary has advanced nanomedicine for single-cell simultaneous diagnostics and therapeutics in vivo. For his body of work, Leary received the 2010 Chairmen's Distinguished Life Scientist Award by the Christopher Columbus Foundation and the U.S. Chamber of Commerce.
He is a member of scientific societies such as the Clinical Cytometry Society, the New York Academy of Sciences, the Optical Society of America, the American Association for the Advancement of Science, a founding member of the International Society for Analytical Cytology, and a fellow of the American Institute for Medical and Biological Sciences. With these and other organizations, Leary contributes to the scientific community as an associate editor for the journal Cytometry: Part A and serves on the editorial boards of the journals Lab on a Chip, BMC Biotechnology, and the Journal of Nanomedicine and Nanotechnology. In addition, he has served on more than 120 National Institutes of Health Study Sections for review of multidisciplinary grants, and he serves on the Scientific Advisory Board of the Glaucoma Foundation.
Leary’s contributions to SPIE conference organization are extensive, having been involved with more than two dozen conferences since 1996. He has served as program committee member and as a co-chair of the Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues conference since 2006, on the program committee for Advanced Biomedical and Clinical Diagnostic Systems conference for six years, and on the program committees for many more conferences covering optical diagnostics, cytology, and biomedical optics.
SPIE, the international society for optics and photonics, was founded in 1955 to advance light-based technologies. Serving more than 180,000 constituents from 168 countries, the Society advances emerging technologies through interdisciplinary information exchange, continuing education, publications, patent precedent, and career and professional growth. SPIE annually organizes and sponsors approximately 25 major technical forums, exhibitions, and education programs in North America, Europe, Asia, and the South Pacific, and supports scholarships, grants, and other education programs around the world. See www.SPIE.org for information.
- Stacey Crockett, Media Relations Coordinator
- +1 360 685 5458
July 9, 2014
Moments after Dr. Jeff Crecelius completes a surgery, hopeful family members typically want to know if he was able to "get it all," or remove all of the cancerous tumor from the brain of a loved one. It's their emotional plea for reassurance. They want to know that the ordeal is completed and that the brain tumor has met its match — the hands of a skilled surgeon.Read Full Story
May 13, 2014
A new alliance focused on aligning resources to advance early stage drug development at top research universities across the state announced its first request for proposals during a retreat hosted by the Indiana Clinical and Translational Sciences Institute at Purdue in West Lafayette, Ind.Read Full Story
April 23, 2014
Purdue University researchers have developed a way to detect and measure cancer levels in a living cell by using tiny gold particles with tails of synthetic DNA.Read Full Story